Tumours of the Pituitary Region

Chapter
First Online:

Abstract

Those interested in a more detailed account of the history of the development of the treatment of pituitary tumours are referred to the excellent chapter of Professor Landolt [1]. A more succinct account may be found in another chapter by Professor Takakura et al. [2]. For the present purpose it is enough to illustrate the canvas of history with broad brush strokes. Horsley is credited with the first successful craniotomy for a pituitary macroadenoma in 1889 [3]. Cushing famous for his work on pituitary adenomas performed 338 operations of which only 107 were undertaken via a craniotomy approach. It is of perhaps only academic interest but his approach was entirely extradural until the level of the sphenoid ridge was reached [4]. His operative mortality was 6.2% and as late as 1959 Krayenbűhl reported an operative mortality of 8.4% [1]. This persistent high mortality led to increased interest in the use of radiotherapy for the treatment of pituitary Macroadenomas, the symptoms of which were due to mass effects.

Keywords

Tumour Volume Pituitary Adenoma Dopamine Agonist Pituitary Tumour Cavernous Sinus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Landolt A. History of pituitary surgery. In: ‘A History of Neurosurgery: in its Scientific and Professional Contexts’, (ed), Greenblatt SD. AANS, Park Ridge, IL: pp 373–400; 1997Google Scholar
  2. 2.
    Takakura K, Hayashi M, Izawa M. Pituitary tumours. In: ‘Principles and Practice of Stereotactic Radiosurgery’, (eds), Chin LS, Regine WF. Heidelberg: Springer Verlag: pp 299–308; 2008CrossRefGoogle Scholar
  3. 3.
    Horsley V. On the techniques of operations on the central nervous system. Br Med J 2: 411–423; 1906CrossRefGoogle Scholar
  4. 4.
    Northfield DWC. The Surgery of the Central Nervous System. Blackwell Scientific Publications, Oxford London: p 308; 1973Google Scholar
  5. 5.
    Northfield DWC. The Surgery of the Central Nervous System. Blackwell Scientific Publications, Oxford London, p 314; 1973Google Scholar
  6. 6.
    Liu JK, Fleseriu M, Delashaw JB Jr, Ciric IS, Couldwell WT. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery. Neurosurg Focus 23(3): E8; 2007PubMedCrossRefGoogle Scholar
  7. 7.
    Degerblad M, Rahn T, Bergstrand G, Thoren M. Long-term results of stereotactic radiosurgery to the pituitary gland in Cushing’s disease. Acta Endocrinol (Copenh) 112(3): 310–314; 1986Google Scholar
  8. 8.
    Hoybye C, Grenback E, Rahn T, Degerblad M, Thoren M, Hulting AL. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49(2): 284–291; 2001PubMedCrossRefGoogle Scholar
  9. 9.
    Andrews DW. Pituitary adenomas. Curr Opin Oncol 6(1): 53–59; 1994PubMedCrossRefGoogle Scholar
  10. 10.
    Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, Conte-Devolx B, Régis J, Brue T. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease. Eur J Endocrinol 156(1): 91–98; 2007PubMedCrossRefGoogle Scholar
  11. 11.
    Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Régis J, Brue T. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94(9): 3400–3407; 2009PubMedCrossRefGoogle Scholar
  12. 12.
    Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Régis J, Dufour H, Brue T. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90(8): 4483–4488; 2005PubMedCrossRefGoogle Scholar
  13. 13.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL. Thyroid-stimulating hormone pituitary adenomas. J Neurosurg 109(1): 17–22; 2008PubMedCrossRefGoogle Scholar
  14. 14.
    Ganz JC. Gamma knife treatment. In: ‘Pituitary Adenomas’, (eds), Landolt AM, Vance ML, Reilly PL. New York, London: Churchill Livingstone: pp 461–474; 1996Google Scholar
  15. 15.
    Ganz JC. Gamma Knife treatment of pituitary adenomas. Stereotact Funct Neurosurg 64(Suppl 1): 3–10; 1995PubMedGoogle Scholar
  16. 16.
    Ganz JC. Radiosurgery for pituitary adenomas. In: ‘Stereotactic and Functional Neurosurgery’, (eds), Gildenberg PL, Tasker RR. New York, Elsevier: pp 845–856; 1998Google Scholar
  17. 17.
    Gutt B, Wowra B, Alexandrov R, Uhl E, Schaaf L, Stalla GK, Schopohl J. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly. Exp Clin Endocrinol Diabetes 113(4): 219–224; 2005PubMedCrossRefGoogle Scholar
  18. 18.
    Iwai Y, Yamanaka K, Yoshioka K, Kanai M. Gamma knife radiosurgery for GH-secreting microadenoma with empty sella. J Clin Neurosci 11(4): 418–421; 2004PubMedCrossRefGoogle Scholar
  19. 19.
    Jane JA Jr, Vance ML, Woodburn CJ, Laws ER Jr. Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 14(5): e12; 2003PubMedCrossRefGoogle Scholar
  20. 20.
    Kanter AS, Diallo AO, Jane JA Jr, Sheehan JP, Asthagiri AR, Oskouian RJ, Okonkwo DO, Sansur CA, Vance ML, Rogol AD, Laws ER Jr. Single-center experience with pediatric Cushing’s disease. J Neurosurg 103(5 Suppl): 413–420; 2005PubMedGoogle Scholar
  21. 21.
    Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res 53(Suppl 3): 71–75; 2000PubMedCrossRefGoogle Scholar
  22. 22.
    Locatelli M, Vance ML, Laws ER. Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 90(9): 5478–5482; 2005PubMedCrossRefGoogle Scholar
  23. 23.
    Mahmoud-Ahmed AS, Suh JH, Mayberg MR. Gamma knife radiosurgery in the management of patients with acromegaly: a review. Pituitary 4(4): 223–230; 2001PubMedCrossRefGoogle Scholar
  24. 24.
    Motti ED, Losa M, Pieralli S, Zecchinelli A, Longobardi B, Giugni E, Ventrella L. Stereotactic radiosurgery of pituitary adenomas. Metabolism 45(8 Suppl 1): 111–114; 1996PubMedCrossRefGoogle Scholar
  25. 25.
    Park YG, Chang JW, Kim EY, Chung SS. Gamma knife surgery in pituitary microadenomas. Yonsei Med J 37(3): 165–173; 1996PubMedGoogle Scholar
  26. 26.
    Picozzi P, Losa M, Mortini P, Valle MA, Franzin A, Attuati L, Ferrari da Passano C, Giovanelli M. Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg 102(Suppl): 71–74; 2005PubMedCrossRefGoogle Scholar
  27. 27.
    Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, Garces YI, Foote RL, Stafford SL, Schomberg PJ. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 70(5): 1325–1329; 2008PubMedCrossRefGoogle Scholar
  28. 28.
    Pollock BE, Young WF Jr. Stereotactic radiosurgery for patients with ACTH-producing pituitary adenomas after prior adrenalectomy. Int J Radiat Oncol Biol Phys 54(3): 839–841; 2002PubMedCrossRefGoogle Scholar
  29. 29.
    Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for nonfunctioning pituitary adenoma. Neurosurg Focus 14(5): e9; 2003PubMedCrossRefGoogle Scholar
  30. 30.
    Swords FM, Monson JP, Besser GM, Chew SL, Drake WM, Grossman AB, Plowman PN. Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy. Eur J Endocrinol 161(6): 819–828; 2009PubMedCrossRefGoogle Scholar
  31. 31.
    Tinnel BA, Henderson MA, Witt TC, Fakiris AJ, Worth RM, Des Rosiers PM, Edmondson JW, Timmerman RD, Lo SS. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma. Stereotact Funct Neurosurg 86(5): 292–296; 2008PubMedCrossRefGoogle Scholar
  32. 32.
    Vladyka V, Liscak R, Novotny JJr, Marek J, Jezkova J. Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52(2): 309–316; 2003PubMedCrossRefGoogle Scholar
  33. 33.
    Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88(7): 3105–3112; 2003PubMedCrossRefGoogle Scholar
  34. 34.
    Jackson IM, Noren G. Role of gamma knife radiosurgery in acromegaly. Pituitary 2(1): 71–77; 1999PubMedCrossRefGoogle Scholar
  35. 35.
    Jackson IM, Noren G. Role of gamma knife therapy in the management of pituitary tumors. Endocrinol Metab Clin North Am 28(1): 133–142; 1999PubMedCrossRefGoogle Scholar
  36. 36.
    Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, Lisak R, Vymazal J, Pecen L. Gamma knife radiosurgery for acromegaly – long-term experience. Clin Endocrinol (Oxf) 64(5): 588–595; 2006CrossRefGoogle Scholar
  37. 37.
    Mingione V, Yen CP, Vance ML, Steiner M, Sheehan J, Laws ER, Steiner L. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg 104(6): 876–883; 2006PubMedCrossRefGoogle Scholar
  38. 38.
    Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4): 678–691; 2005PubMedCrossRefGoogle Scholar
  39. 39.
    Kobayashi T, Kida Y, Mori Y. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J Neurosurg 97(5 Suppl): 422–428; 2002PubMedGoogle Scholar
  40. 40.
    Vladyka V, Liscak R, Subrt O, Simonova G, Novotny J. Use of the radiosurgery knife in the treatment of hypophyseal adenomas. Cas Lek Cesk 134(17): 539–542; 1995PubMedGoogle Scholar
  41. 41.
    Ma ZM, Qiu B, Hou YH, Liu YS. Gamma knife treatment for pituitary prolactinomas. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31(5): 714–716; 2006PubMedGoogle Scholar
  42. 42.
    Pan L, Zhang N, Wang EM, Wang BJ, Dai JZ, Cai PW. Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg 93(Suppl 3): 10–13; 2000PubMedGoogle Scholar
  43. 43.
    Yuan YH, Dong XM, Yu HW, Guan JH, Wang CL. Gamma knife for hypersecreting pituitary adenom: analysis of 120 cases. Zhonghua Wai Ke Za Zhi 44(6): 416–419; 2006PubMedGoogle Scholar
  44. 44.
    Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW. Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg 93(Suppl 3): 6–9; 2000PubMedGoogle Scholar
  45. 45.
    Feigl GC, Bonelli CM, Berghold A, Mokry M. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97(5 Suppl): 415–421; 2002PubMedGoogle Scholar
  46. 46.
    Jackson IM, Noren G. Gamma knife radiosurgery for pituitary tumours. Baillieres Best Pract Res Clin Endocrinol Metab 13(3): 461–469; 1999PubMedCrossRefGoogle Scholar
  47. 47.
    Kim M, Paeng S, Pyo S, Jeong Y, Lee S, Jung Y. Gamma knife surgery for invasive pituitary macroadenoma. J Neurosurg 105(Suppl): 26–30; 2006PubMedGoogle Scholar
  48. 48.
    Losa M, Valle M, Mortini P, Franzin A, da Passano CF, Cenzato M, Bianchi S, Picozzi P, Giovanelli M. Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100(3): 438–444; 2004PubMedCrossRefGoogle Scholar
  49. 49.
    Muacevic A, Uhl E, Wowra B. Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir Suppl 91: 51–54; 2004PubMedGoogle Scholar
  50. 50.
    Thoren M, Hoybye C, Grenback E, Degerblad M, Rahn T, Hulting AL. The role of gamma knife radiosurgery in the management of pituitary adenomas. J Neurooncol 54(2): 197–203; 2001PubMedCrossRefGoogle Scholar
  51. 51.
    Wowra B, Stummer W. Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg 97(5 Suppl): 429–432; 2002PubMedGoogle Scholar
  52. 52.
    Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97(5 Suppl): 408–414; 2002PubMedGoogle Scholar
  53. 53.
    Vladyka V, Liscak R, Simonova G, Chytka T, Novotny J Jr, Vymazal J, Marek J, Hana V, Vavros D. Radiosurgical treatment of hypophyseal adenomas with the gamma knife: results in a group of 163 patients during a 5-year period. Cas Lek Cesk 139(24): 757–766; 2000PubMedGoogle Scholar
  54. 54.
    Lim YL, Leem W, Kim TS, Rhee BA, Kim GK. Four years’ experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 70(Suppl 1): 95–109; 1998PubMedCrossRefGoogle Scholar
  55. 55.
    Iwai Y, Yamanaka K, Yoshioka K Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery 56(4): 699–705; 2005PubMedCrossRefGoogle Scholar
  56. 56.
    Mokry M, Ramschak-Schwarzer S, Simbrunner J, Ganz JC, Pendl G. A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1): 88–100; 1999PubMedCrossRefGoogle Scholar
  57. 57.
    Petrovich Z, Yu C, Giannotta SL, Zee CS, Apuzzo ML. Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53(1): 51–59; 2003PubMedCrossRefGoogle Scholar
  58. 58.
    Ronchi CL, Attanasio R, Verrua E, Cozzi R, Ferrante E, Loli P, Montefusco L, Motti E, Ferrari DI, Giugni E, Beck-Peccoz P, Arosio M. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study Clin Endocrinol (Oxf); 2009 [epub ahead of print]Google Scholar
  59. 59.
    Seo Y, Fukuoka S, Takanashi M, Sasaki T, Suematsu K, Nakamura J. Gamma knife surgery for Cushing’s disease. Surg Neurol 43(2): 170–175l; 1995PubMedCrossRefGoogle Scholar
  60. 60.
    Shin M, Kurita H, Sasaki T, Tago M, Morita A, Ueki K, Kirino T. Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus. J Neurosurg 93(Suppl 3): 2–5; 2000PubMedGoogle Scholar
  61. 61.
    Vik-Mo E, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rodahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M. Gamma knife sterotactic radiosurgery of Nelson syndrome Eur J Endocrinol 160(2): 143–148; 2009PubMedCrossRefGoogle Scholar
  62. 62.
    Ganz JC, El Shehaby A, Reda WA, Abdelkarim K. Protection of the anterior visual pathways during gamma knife treatment of meningiomas. Br J Neurosurg 24(3): 248–258; 2010CrossRefGoogle Scholar
  63. 63.
    Pollock BE. Stereotactic radiosurgery for intracranial meningiomas: indications and results. Neurosurg Focus 14(5): e4; 2003PubMedCrossRefGoogle Scholar
  64. 64.
    Rowe JG, Walton L, Vaughan P, Malik I, Radatz M, Kemeny A. Radiosurgical planning of meningiomas: compromises with conformity. Stereotact Funct Neurosurg 82(4): 169–174; 2004PubMedCrossRefGoogle Scholar
  65. 65.
    Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML. Gamma Knife surgery for Cushing’s disease. J Neurosurg 106: 980–987; 2007PubMedCrossRefGoogle Scholar
  66. 66.
    Jagannathan J, Sheehan JP, Pouratian N, Laws ER Jr, Steiner L, Vance ML. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 62(6): 1262–1269; 2008PubMedCrossRefGoogle Scholar
  67. 67.
    Liscak R, Vladyka V, Marek J, Simonova G, Vymazal J. Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir 149: 999–1006; 2007PubMedCrossRefGoogle Scholar
  68. 68.
    Marek J, Malik J, Fendrych P. Initial experience of an endocrinologist with the treatment of hypophyseal adenomas with the Leksell gamma knife. Cas Lek Cesk 134(17): 543–546; 1995PubMedGoogle Scholar
  69. 69.
    Martinez R, Bravo G, Burzaco J, Rey G. Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg 70(Suppl 1): 110–118; 1998PubMedCrossRefGoogle Scholar
  70. 70.
    Mauermann WJ, Sheehan JP, Chernavvsky DR, Laws ER, Steiner L, Vance ML. Gamma knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy. J Neurosurg 106: 988–993; 2007PubMedCrossRefGoogle Scholar
  71. 71.
    Pollock BE, Brown PD, Nippoldt TB, Young WF Jr. Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery 62(6): 1271–1276; 2008PubMedCrossRefGoogle Scholar
  72. 72.
    Pollock BE, Jacob JT, Brown PD, Nippoldt TB. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106: 833–838; 2007PubMedCrossRefGoogle Scholar
  73. 73.
    Pollock BE, Nippoldt TB, Stafford SL, Foote RL, Abboud CF. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 97(3): 525–530; 2002PubMedCrossRefGoogle Scholar
  74. 74.
    Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML. Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59(2): 255–266; 2006PubMedCrossRefGoogle Scholar
  75. 75.
    Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Laws ER Jr. Radiosurgery for Cushing’s disease after failed transsphenoidal surgery. J Neurosurg 93(5): 738–742; 2000PubMedCrossRefGoogle Scholar
  76. 76.
    Thoren M, Rahn T, Guo WY, Werner S. Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors. Neurosurgery 29(5): 663–668; 1991PubMedCrossRefGoogle Scholar
  77. 77.
    Lim YJ, Leem W, Park JT, Kim TS, Rhee BA, Kim GK. Cerebral infarction with ICA occlusion after gamma knife radiosurgery for pituitary adenoma: a case report. Stereotact Funct Neurosurg 72(Suppl 1): 132–139; 1999PubMedCrossRefGoogle Scholar
  78. 78.
    Iwai Y, Yamanaka K, Yoshioka K, Yoshimura M, Honda Y, Matsusaka Y, Komiyama M, Yasui T. The usefulness of adjuvant therapy using gamma knife radiosurgery for the recurrent or residual nonfunctioning pituitary adenomas. No Shinkei Geka 33(8): 777–783; 2005PubMedGoogle Scholar
  79. 79.
    Ganz JC, Aanderud S, Mørk S, Smieveoll A-I. Tumour volume reduction following gamma knife radiosurgery: the relationship between X-ray and histological findings. In: ‘Advances in Radiosurgery’, (eds), Lindquist C, KondziolkaD, Loeffler J. Vienna, New York: Springer Verlag: pp 39–42; 1994CrossRefGoogle Scholar
  80. 80.
    Jeffcoate WF. Treating Cushing’s disease. Br Med J 296: 227–228; 1988CrossRefGoogle Scholar
  81. 81.
    Choi JY, Chang JH, Chang JW, Ha Y, Park YG, Chung SS. Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery. Yonsei Med J 44(4): 602–607; 2003PubMedGoogle Scholar
  82. 82.
    Morange-Ramos I, Régis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, Peragut JC. Short-term endocrinological results after gamma knife surgery of pituitary adenomas. Stereotact Funct Neurosurg 70(Suppl 1): 127–138; 1998PubMedCrossRefGoogle Scholar
  83. 83.
    Pouratian N, Prevedello DM, Jagannathan J, Lopes MB, Vance ML, Laws ER Jr. Outcomes and management of patients with Cushing’s disease without pathological confirmation of tumor resection after transsphenoidal surgery. J Clin Endocrinol Metab 92(9): 3383–3388; 2007PubMedCrossRefGoogle Scholar
  84. 84.
    Ayuk J, Sheppard MC. Does Acromegaly enhance mortality? Rev Endocr Metab Disord 9(1): 33–39; 2008PubMedCrossRefGoogle Scholar
  85. 85.
    Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani S. Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure? J Neurosurg 102(Suppl): 119–123; 2005PubMedCrossRefGoogle Scholar
  86. 86.
    Wang MH, Liu P, Liu AL, Luo B, Sun SB. Efficacy of gamma knife radiosurgery in treatment of growth hormone-secreting pituitary adenoma. Zhonghua Yi Xue Za Zhi 83(23): 2045–2048; 2003PubMedGoogle Scholar
  87. 87.
    Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 88(6): 1002–1008; 1998PubMedCrossRefGoogle Scholar
  88. 88.
    Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85(3): 1287–1289; 2000PubMedCrossRefGoogle Scholar
  89. 89.
    Killinger D, Gonzales J, Horvath E, Kovacs K, Smyth H. Correlation between pre-operative testing and tumour morphology in acromegaly. In: ‘Sandostatin in the Treatment of Acromegaly’, (ed), Lamberts SWJ. Berlin, Heidelberg, New York: Springer Verlag: pp 9–16; 1988CrossRefGoogle Scholar
  90. 90.
    von Werder K. Prolactinoma: clinical findings and endocrinology. In: 'Pituitary Adenomas', (eds), Landolt AM, Vance ML, Reilly PL. New York, London: Churchill Livingstone: pp 111–126; 1996Google Scholar
  91. 91.
    Jagannathan J, Yen CP, Pouratian N, Laws ER, Sheehan JP. Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the gamma knife. J Neurooncol 92(3): 345–356; 2009PubMedCrossRefGoogle Scholar
  92. 92.
    Kim MS, Lee SI, Sim JH. Gamma knife radiosurgery for functioning pituitary microadenoma. Stereotact Funct Neurosurg 72(Suppl 1): 119–124; 1999PubMedCrossRefGoogle Scholar
  93. 93.
    Kim SH, Huh R, Chang JW, Park YG, Chung SS. Gamma Knife radiosurgery for functioning pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1): 101–110; 1999PubMedCrossRefGoogle Scholar
  94. 94.
    Endocrine-inactive, FSH, LH and α-SU adenomas. In: ‘Pituitary Adenomas’, (eds), Landolt AM, Vance ML, Reilly PL. New York, London: Churchill Livingstone: pp 127–138; 1996Google Scholar
  95. 95.
    Hayashi M, Izawa M, Hiyama H, Nakamura S, Atsuchi S, Sato H, Nakaya K, Sasaki K, Ochiai T, Kubo O, Hori T, Takakura K. Gamma Knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1): 111–118; 1999PubMedCrossRefGoogle Scholar
  96. 96.
    Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, Takakura K. Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93(Suppl 3): 19–22; 2000PubMedGoogle Scholar
  97. 97.
    Qiu B, Ma ZM, Liu YS, Hou YH, Tang JB. Gamma knife treatment for pituitary adenomas. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29(4): 463–466; 2004PubMedGoogle Scholar
  98. 98.
    Shin M. Gamma knife radiosurgery for pituitary adenoma. Biomed Pharmacother 56(Suppl): 1178s–1181s; 2002Google Scholar
  99. 99.
    Backlund EO. Colloidal radioisotopes as part of a multi-modality treatmentof craniopharyngiomas. J Neurosurg Sci 33(1): 95–97; 1989PubMedGoogle Scholar
  100. 100.
    Albright AL, Hadjipanayis CG, Lunsford LD, Kondziolka D, Pollack IF, Adelson PD. Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst 21(8–9): 649–654; 2005PubMedCrossRefGoogle Scholar
  101. 101.
    Barajas MA, Ramirez-Guzman G, Rodriguez-Vazquez C, Toledo-Buenrostro V, Velasquez-Santana H, del Robles RV, Cuevas-Solorzano A, Rodriguez-Hernandez G. Multimodal management of craniopharyngiomas: neuroendoscopy, microsurgery, and radiosurgery. J Neurosurg 97(5 Suppl): 607–609; 2002PubMedGoogle Scholar
  102. 102.
    Chiou SM, Lunsford LD, Niranjan A, Kondziolka D, Flickinger JC. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro Oncol 3(3): 159–166; 2001PubMedGoogle Scholar
  103. 103.
    Chung WY, Pan DH, Shiau CY, Guo WY, Wang LW. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 93(Suppl 3): 47–56; 2000PubMedGoogle Scholar
  104. 104.
    Kobayashi T, Kida Y, Mori Y, Hasegawa T. Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg 103(6 Suppl): 482–488; 2005PubMedGoogle Scholar
  105. 105.
    Ulfarsson E, Lindquist C, Roberts M, Rahn T, Lindquist M, Thoren M, Lippitz B. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 97(5 Suppl): 613–622; 2002PubMedGoogle Scholar
  106. 106.
    Elliott RE, Hsieh K, Hochman T, Belitskaya-Levy I, Wisoff J, Wisoff JH. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr 5(1): 30–48; 2010PubMedCrossRefGoogle Scholar
  107. 107.
    Amendola BE, Wolf A, Coy SR, Amendola MA. Role of radiosurgery in craniopharyngiomas: a preliminary report. Med Pediatr Oncol 41(2): 123–127; 2003PubMedCrossRefGoogle Scholar
  108. 108.
    Chung WY, Pan HC, Guo WY, Shiau CY, Wang LW, Wu HM, Lee LS. Protection of visual pathway in gamma knife radiosurgery for craniopharyngiomas. Stereotact Funct Neurosurg 70(Suppl 1): 139–151; 1998PubMedCrossRefGoogle Scholar
  109. 109.
    Mokry M. Craniopharyngiomas: a six year experience with gamma knife radiosurgery. Stereotact Funct Neurosurg 72(Suppl 1): 140–149; 1999PubMedCrossRefGoogle Scholar
  110. 110.
    Niranjan A, Kano H, Mathieu D, Kondziolka D, Flickinger JC, Lunsford LD. Radiosurgery for Craniopharyngioma Int J Radiat Oncol Biol Phys 78(1):64–71; 2010Google Scholar
  111. 111.
    Yomo S, Hayashi M, Chernov M, Tamura N, Izawa M, Okada Y, Hori T, Iseki H. Stereotactic radiosurgery of residual or recurrent craniopharyngioma: new treatment concept using Leksell gamma knife model C with automatic positioning system. Stereotact Funct Neurosurg 87(6): 360–367; 2009PubMedCrossRefGoogle Scholar
  112. 112.
    Kobayashi T, Tanaka T, Kida Y. Stereotactic gamma radiosurgery of craniopharyngiomas. Pediatr Neurosurg 21(Suppl 1): 69–74; 1994PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2011

Authors and Affiliations

  1. 1.BergenNorway

Personalised recommendations